瑞康医药

- 002589

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
瑞康医药(002589) 利润表
单位:万元
报表日期2025-09-302025-06-302025-03-312024-12-312024-09-30
一、营业总收入540,653.36354,352.02175,665.05796,634.56605,619.45
营业收入540,653.36354,352.02175,665.05796,634.56605,619.45
二、营业总成本545,525.30362,752.79176,461.69801,936.59599,770.54
营业成本478,219.12316,686.17151,339.92709,014.28526,553.05
营业税金及附加2,813.021,569.84949.003,691.112,680.09
销售费用25,967.3918,181.228,368.8136,048.8827,535.72
管理费用26,553.0017,015.8310,591.3639,489.8429,325.23
财务费用10,322.188,179.884,917.1712,689.5612,919.86
研发费用1,650.581,119.84295.431,002.91756.60
资产减值损失----------
公允价值变动收益-89.09-89.09-89.093,064.711,246.45
投资收益1,677.641,240.49523.309,621.312,901.49
其中:对联营企业和合营企业的投资收益-------12.74--
汇兑收益----------
三、营业利润1,652.72-1,881.882,367.962,553.285,333.65
加:营业外收入457.29449.1843.422,033.67185.03
减:营业外支出1,655.50105.8272.18430.07807.29
其中:非流动资产处置损失----------
四、利润总额454.50-1,538.532,339.204,156.884,711.38
减:所得税费用-2,245.91-4,599.03395.6655.10-513.52
五、净利润2,700.413,060.501,943.544,101.785,224.90
归属于母公司所有者的净利润1,213.661,816.641,417.112,062.163,880.63
少数股东损益1,486.751,243.86526.432,039.621,344.27
六、每股收益
基本每股收益(元/股)0.00810.01210.00940.01370.0258
稀释每股收益(元/股)0.00810.01210.00940.01370.0258
七、其他综合收益----------
八、综合收益总额2,700.413,060.501,943.544,101.785,224.90
归属于母公司所有者的综合收益总额1,213.661,816.641,417.112,062.163,880.63
归属于少数股东的综合收益总额1,486.751,243.86526.432,039.621,344.27
下载全部历史数据到excel中 返回页顶